Showing results (611-620 of 829) with videos related to

Sort By:
Pageof 83
Revue Neurologique|October 15, 2024
Migraine treatment: Position paper of the French Headache SocietyX Moisset, G Demarquay, S de Gaalon, et al.
Stroke|July 24, 2026
Delayed Recognition and Stroke-Predominant Presentation in Down Syndrome-Associated Moyamoya SyndromeJonathan D Santoro, Mackenzie Silverman, Anthony C Wang, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 6, 2011
The FEMA GRAS assessment of aliphatic and aromatic terpene hydrocarbons used as flavor ingredientsT B Adams, C Lucas Gavin, M M McGowen, et al.
Cell Reports|June 19, 2012
Bcl10 links saturated fat overnutrition with hepatocellular NF-kB activation and insulin resistanceMatthew Van Beek, Katherine I Oravecz-Wilson, Phillip C Delekta, et al.
Plos One|August 18, 2018
Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutationsRekha Pal, Ning Wei, Nan Song, et al.
Molecular Autism|January 29, 2026
Serum and cerebral folate are normal in down syndrome regression disorderJonathan D Santoro, Mackenzie Silverman, Lilia Kazerooni, et al.
International Journal of Biological Macromolecules|January 28, 2014
Physicochemical, morphological, and rheological characterization of Xanthosoma robustum Lego-like starchSandra M Londoño-Restrepo, Natalia Rincón-Londoño, Margarita Contreras-Padilla, et al.
Scientific Data|March 20, 2026
An ontology-based description of nano computed tomography measurements in electronic laboratory notebooksF Kirchner, D C F Wieland, S Irvine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2015
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)M De Santis, P J Wiechno, J Bellmunt, et al.
Cancer Letters|June 24, 2019
Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinomaLan Cao, Ahmed Basudan, Matthew J Sikora, et al.
Pageof 83